Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like cells able to regenerate retinal tissue and support visual recovery.

Scientists have for the first time looked deep into the protein structure that may determine our vision - and discovered that ...

Transplantation of retinal organoid sheets offers hope to patients afflicted with retinal degenerative diseases.

Researchers have developed a groundbreaking eye drop treatment that slows vision loss in animal models of retinitis pigmentosa, a group of inherited diseases that cause progressive blindness in humans ...

Researchers have successfully developed a novel drug to restore vision. The treatment method restores vision through retinal nerve regeneration.

Washington DC [US], March 24 (ANI): Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as ...

When administered once daily to young mice with retinitis pigmentosa-like disease, H105A slowed photoreceptor degeneration and vision loss. To test the drops, the investigators used specially bred ...

Complete Blindness: Individuals with complete blindness (total vision loss) are unable to perceive light or any visual stimuli. Progressive Eye Conditions: Some conditions, such as glaucoma, retinitis ...

Vision is one of the most crucial human senses, yet more than 300 million people worldwide are at risk of vision loss due to ...

"We are excited by the therapeutic benefits seen in retinitis pigmentosa patients with progressive ... technology to help those with severe vision loss due to retinal degenerative diseases." ...

It is approved for treating vision loss caused by Leber's congenital amaurosis or retinitis pigmentosa due to confirmed biallelic RPE65 mutations. LUXTURNA uses an adeno-associated viral type 2 (AAV2) ...